Advertisement
UK markets close in 3 hours 59 minutes
  • FTSE 100

    8,064.23
    +40.36 (+0.50%)
     
  • FTSE 250

    19,730.75
    +131.36 (+0.67%)
     
  • AIM

    753.86
    +4.68 (+0.62%)
     
  • GBP/EUR

    1.1608
    +0.0019 (+0.16%)
     
  • GBP/USD

    1.2388
    +0.0038 (+0.30%)
     
  • Bitcoin GBP

    53,359.46
    +129.25 (+0.24%)
     
  • CMC Crypto 200

    1,423.28
    +8.52 (+0.60%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • DOW

    38,239.98
    +253.58 (+0.67%)
     
  • CRUDE OIL

    81.51
    -0.39 (-0.48%)
     
  • GOLD FUTURES

    2,314.50
    -31.90 (-1.36%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • DAX

    18,072.69
    +211.89 (+1.19%)
     
  • CAC 40

    8,103.59
    +63.23 (+0.79%)
     

Is Now The Time To Put Rentokil Initial (LON:RTO) On Your Watchlist?

Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story stocks' without revenue, let alone profit. And in their study titled Who Falls Prey to the Wolf of Wall Street?' Leuz et. al. found that it is 'quite common' for investors to lose money by buying into 'pump and dump' schemes.

If, on the other hand, you like companies that have revenue, and even earn profits, then you may well be interested in Rentokil Initial (LON:RTO). While that doesn't make the shares worth buying at any price, you can't deny that successful capitalism requires profit, eventually. Conversely, a loss-making company is yet to prove itself with profit, and eventually the sweet milk of external capital may run sour.

Check out our latest analysis for Rentokil Initial

Rentokil Initial's Earnings Per Share Are Growing.

The market is a voting machine in the short term, but a weighing machine in the long term, so share price follows earnings per share (EPS) eventually. That makes EPS growth an attractive quality for any company. We can see that in the last three years Rentokil Initial grew its EPS by 11% per year. That growth rate is fairly good, assuming the company can keep it up.

ADVERTISEMENT

One way to double-check a company's growth is to look at how its revenue, and earnings before interest and tax (EBIT) margins are changing. Rentokil Initial shareholders can take confidence from the fact that EBIT margins are up from 10% to 13%, and revenue is growing. Ticking those two boxes is a good sign of growth, in my book.

In the chart below, you can see how the company has grown earnings, and revenue, over time. Click on the chart to see the exact numbers.

earnings-and-revenue-history
earnings-and-revenue-history

The trick, as an investor, is to find companies that are going to perform well in the future, not just in the past. To that end, right now and today, you can check our visualization of consensus analyst forecasts for future Rentokil Initial EPS 100% free.

Are Rentokil Initial Insiders Aligned With All Shareholders?

We would not expect to see insiders owning a large percentage of a UK£10b company like Rentokil Initial. But we do take comfort from the fact that they are investors in the company. Indeed, they hold UK£9.9m worth of its stock. That shows significant buy-in, and may indicate conviction in the business strategy. Despite being just 0.09% of the company, the value of that investment is enough to show insiders have plenty riding on the venture.

Should You Add Rentokil Initial To Your Watchlist?

As I already mentioned, Rentokil Initial is a growing business, which is what I like to see. If that's not enough on its own, there is also the rather notable levels of insider ownership. That combination appeals to me, for one. So yes, I do think the stock is worth keeping an eye on. You should always think about risks though. Case in point, we've spotted 1 warning sign for Rentokil Initial you should be aware of.

Although Rentokil Initial certainly looks good to me, I would like it more if insiders were buying up shares. If you like to see insider buying, too, then this free list of growing companies that insiders are buying, could be exactly what you're looking for.

Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.